More recently, tumor-infiltrating T cells in human lung cancer have been shown to cross-react with a tumor antigen derived from the TMEM161A protein and an antigen derived from the Epstein-Barr virus (EBV) latent membrane protein 2a. This evidence concerns the gene TMEM161A and neoplasm.